Tumor-associated entry receptor

The term "Tumor-associated entry receptor" refers to a functional class of cell surface proteins that facilitate the entry of therapeutic agents, such as oncolytic viruses or targeted toxins, into malignant cells (PMC3921180). These receptors are typically overexpressed or uniquely present on the surface of tumor cells compared to normal tissues, providing a mechanism for selective targeting. Common examples of identified receptors in this category include Nectin-4 for Measles virus and various integrins or growth factor receptors for engineered Adenoviruses (PMC3921180). However, the designation "Unknown" in the original query indicates that the specific molecular identity of the receptor mediating entry has not been characterized in a particular experimental or clinical context. Because it is a descriptive category rather than a specific molecular entity, it does not have a canonical sequence, defined structure, or specific pharmacological profile. In drug development, identifying the exact receptor is crucial for assessing off-target risks and optimizing the therapeutic index of the agent. As such, this is considered an incomplete or generic entry rather than a validated therapeutic target. Therapeutic strategies involving these receptors often focus on retargeting viral tropism to enhance anti-tumor efficacy while sparing healthy cells.

Other names

Tumor-associated receptorsViral entry receptors

Not applicable for unidentified receptors.